Fluoropharma Medical Inc (FPMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25 | 28 | 408 | 41 | 291 |
| TOTAL | $48 | $89 | $464 | $138 | $509 |
| Non-Current Assets | |||||
| PPE Net | 7 | 9 | 10 | 10 | 11 |
| Intangibles | 280 | 289 | 299 | 309 | 319 |
| TOTAL | $287 | $298 | $309 | $319 | $330 |
| Total Assets | $335 | $387 | $773 | $457 | $839 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,414 | 1,323 | 1,401 | 1,298 | 1,220 |
| Accrued Expenses | 2,616 | 2,352 | 2,348 | 1,584 | 1,604 |
| Other current liabilities | 252 | 826 | 1,649 | 1,993 | 1,526 |
| TOTAL | $10,514 | $10,319 | $10,961 | $9,912 | $8,699 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 408 | 183 | 183 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10,514 | $10,319 | $10,961 | $9,912 | $8,699 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,262 | 34,074 | 33,757 | 33,355 | 33,220 |
| Common Shares | 34 | 34 | 34 | 33 | 33 |
| Retained earnings | -35,178 | -34,926 | -35,177 | -34,310 | -32,604 |
| TOTAL | $-10,179 | $-9,932 | $-10,189 | $-9,455 | $-7,860 |
| Total Liabilities And Equity | $335 | $387 | $773 | $457 | $839 |